Crossmark

Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain

Crossref DOI link: https://doi.org/10.1016/j.pain.2013.05.043

Published Print: 2013-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Tesfaye, Solomon

Wilhelm, Stefan

Lledo, Alberto

Schacht, Alexander

Tölle, Thomas

Bouhassira, Didier

Cruccu, Giorgio

Skljarevski, Vladimir

Freynhagen, Rainer
License Information

Text and Data Mining valid from 2013-12-01
More Information

This article is maintained by: Elsevier

Article Title: Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain

Journal Title: PAIN®

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pain.2013.05.043

Content Type: article

Copyright: Crown copyright © 2013 Published by Elsevier B.V.

Document is current

Any future updates will be listed below